Neurobiological Technologies, Inc. Share Price Other OTC
Equities
NTII
US64124W3043
Pharmaceuticals
Sales 2008 | 14.76M 1.17B | Sales 2009 | 26.35M 2.1B | Capitalization | 18.18M 1.45B |
---|---|---|---|---|---|
Net income 2008 | -16M -1.27B | Net income 2009 | 3M 239M | EV / Sales 2008 | 0.56 x |
Net cash position 2008 | 29.98M 2.39B | Net cash position 2009 | 24.05M 1.91B | EV / Sales 2009 | -0.22 x |
P/E ratio 2008 |
-1.69
x | P/E ratio 2009 |
5.82
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+29.90% | 662B | |
+21.96% | 546B | |
-5.33% | 359B | |
+16.80% | 323B | |
+4.56% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.92% | 167B |